1. Home
  2. CRT vs ABVC Comparison

CRT vs ABVC Comparison

Compare CRT & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRT
  • ABVC
  • Stock Information
  • Founded
  • CRT 1991
  • ABVC 2015
  • Country
  • CRT United States
  • ABVC United States
  • Employees
  • CRT N/A
  • ABVC N/A
  • Industry
  • CRT Oil & Gas Production
  • ABVC Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRT Energy
  • ABVC Health Care
  • Exchange
  • CRT Nasdaq
  • ABVC Nasdaq
  • Market Cap
  • CRT 65.1M
  • ABVC 52.1M
  • IPO Year
  • CRT 1992
  • ABVC N/A
  • Fundamental
  • Price
  • CRT $7.73
  • ABVC $2.85
  • Analyst Decision
  • CRT
  • ABVC
  • Analyst Count
  • CRT 0
  • ABVC 0
  • Target Price
  • CRT N/A
  • ABVC N/A
  • AVG Volume (30 Days)
  • CRT 23.2K
  • ABVC 94.1K
  • Earning Date
  • CRT 01-01-0001
  • ABVC 11-13-2025
  • Dividend Yield
  • CRT 11.47%
  • ABVC N/A
  • EPS Growth
  • CRT N/A
  • ABVC N/A
  • EPS
  • CRT 0.92
  • ABVC N/A
  • Revenue
  • CRT $6,559,820.00
  • ABVC $391,242.00
  • Revenue This Year
  • CRT N/A
  • ABVC $735.18
  • Revenue Next Year
  • CRT N/A
  • ABVC N/A
  • P/E Ratio
  • CRT $8.74
  • ABVC N/A
  • Revenue Growth
  • CRT N/A
  • ABVC 186.84
  • 52 Week Low
  • CRT $7.75
  • ABVC $0.40
  • 52 Week High
  • CRT $13.31
  • ABVC $5.48
  • Technical
  • Relative Strength Index (RSI)
  • CRT 17.95
  • ABVC 49.59
  • Support Level
  • CRT $8.46
  • ABVC $2.64
  • Resistance Level
  • CRT $8.79
  • ABVC $2.90
  • Average True Range (ATR)
  • CRT 0.17
  • ABVC 0.15
  • MACD
  • CRT -0.07
  • ABVC 0.01
  • Stochastic Oscillator
  • CRT 5.25
  • ABVC 54.05

About CRT Cross Timbers Royalty Trust

Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.

About ABVC ABVC BioPharma Inc.

ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

Share on Social Networks: